These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17209779)

  • 1. Characterization of minocycline transport by human neutrophils.
    Walters JD
    J Periodontol; 2006 Dec; 77(12):1964-8. PubMed ID: 17209779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro model of ciprofloxacin and minocycline transport by oral epithelial cells.
    Brayton JJ; Yang Q; Nakkula RJ; Walters JD
    J Periodontol; 2002 Nov; 73(11):1267-72. PubMed ID: 12479629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of ciprofloxacin and minocycline by cultured human gingival fibroblasts.
    Yang Q; Nakkula RJ; Walters JD
    J Dent Res; 2002 Dec; 81(12):836-40. PubMed ID: 12454098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration of 3 tetracyclines in plasma, gingival crevice fluid and saliva.
    Sakellari D; Goodson JM; Kolokotronis A; Konstantinidis A
    J Clin Periodontol; 2000 Jan; 27(1):53-60. PubMed ID: 10674962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of gingival fibroblast minocycline accumulation by biological mediators.
    Walters JD; Nakkula RJ; Maney P
    J Dent Res; 2005 Apr; 84(4):320-3. PubMed ID: 15790736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of fluoroquinolone transport by human neutrophils.
    Walters JD; Zhang F; Nakkula RJ
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2710-5. PubMed ID: 10543751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical use of tetracyclines in the treatment of periodontal diseases].
    Bokor-Bratić M; Brkanić T
    Med Pregl; 2000; 53(5-6):266-71. PubMed ID: 11089368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the antinociceptive and anti-inflammatory activities of doxycycline and minocycline in different experimental models.
    Bastos LF; Merlo LA; Rocha LT; Coelho MM
    Eur J Pharmacol; 2007 Dec; 576(1-3):171-9. PubMed ID: 17719028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines.
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2628-32. PubMed ID: 7872759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of tetracyclines on human polymorphonuclear leukocyte function.
    Glette J; Sandberg S; Hopen G; Solberg CO
    Antimicrob Agents Chemother; 1984 Mar; 25(3):354-7. PubMed ID: 6721468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of doxycycline and minocycline.
    Saivin S; Houin G
    Clin Pharmacokinet; 1988 Dec; 15(6):355-66. PubMed ID: 3072140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between HMR 3647, a new ketolide, and human polymorphonuclear neutrophils.
    Vazifeh D; Preira A; Bryskier A; Labro MT
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1944-51. PubMed ID: 9687388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minocycline affects human neutrophil respiratory burst and transendothelial migration.
    Parenti A; Indorato B; Paccosi S
    Inflamm Res; 2017 Feb; 66(2):107-109. PubMed ID: 27757474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of human neutrophil functions by tetracyclines.
    Gabler WL; Creamer HR
    J Periodontal Res; 1991 Jan; 26(1):52-8. PubMed ID: 1847418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minocycline and doxycycline, but not other tetracycline-derived compounds, protect liver cells from chemical hypoxia and ischemia/reperfusion injury by inhibition of the mitochondrial calcium uniporter.
    Schwartz J; Holmuhamedov E; Zhang X; Lovelace GL; Smith CD; Lemasters JJ
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):172-9. PubMed ID: 24012766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetration, efflux and intracellular activity of tigecycline in human polymorphonuclear neutrophils (PMNs).
    Ong CT; Babalola CP; Nightingale CH; Nicolau DP
    J Antimicrob Chemother; 2005 Sep; 56(3):498-501. PubMed ID: 16024591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considerations for using minocycline vs doxycycline for treatment of canine heartworm disease.
    Papich MG
    Parasit Vectors; 2017 Nov; 10(Suppl 2):493. PubMed ID: 29143669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of therapeutic levels of doxycycline and minocycline in the proliferation and differentiation of human bone marrow osteoblastic cells.
    Gomes PS; Fernandes MH
    Arch Oral Biol; 2007 Mar; 52(3):251-9. PubMed ID: 17141175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response effect of tetracyclines on cerebral matrix metalloproteinase-9 after vascular endothelial growth factor hyperstimulation.
    Lee CZ; Yao JS; Huang Y; Zhai W; Liu W; Guglielmo BJ; Lin E; Yang GY; Young WL
    J Cereb Blood Flow Metab; 2006 Sep; 26(9):1157-64. PubMed ID: 16395286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of tetracycline, minocycline and doxycycline in treatment of acute-on-chronic bronchitis. A study based on sputum levels.
    Ruhen RW; Tandon MK
    Med J Aust; 1976 Feb; 1(6):151-3. PubMed ID: 1083475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.